Xinfa Pharmaceutical
Xinfa Pharmaceutical Co., Ltd., commonly referred to as Xinfa Pharma, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1995, the company has made significant strides in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms, primarily serving the global market. With a strong operational presence in Asia and beyond, Xinfa Pharma focuses on a diverse range of therapeutic areas, including cardiovascular, anti-infective, and central nervous system medications. The company is renowned for its commitment to innovation and quality, which has positioned it as a trusted supplier in the pharmaceutical sector. Notable achievements include various certifications and partnerships that underscore its market position, making Xinfa Pharma a key contributor to the global healthcare landscape.
DitchCarbon Score
How does Xinfa Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Xinfa Pharmaceutical's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Xinfa Pharmaceutical's reported carbon emissions
Xinfa Pharmaceutical, headquartered in CN, currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. The absence of documented reduction initiatives suggests that Xinfa Pharmaceutical may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly prioritises sustainability, it will be essential for Xinfa to establish clear climate commitments and measurable targets to align with global efforts in reducing greenhouse gas emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Xinfa Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
